Miranda, Marissa C.
HRN: 22-07-18 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2024
CEFTRIAXONE 1G (VIAL)
03/20/2024
03/27/2024
IV
2gram
OD
CAP
Waiting Final Action
03/20/2024
AZITHROMYCIN 500MG TABLET (TAB)
03/20/2024
03/27/2024
PO
500mg
OD
CAP
Waiting Final Action
03/21/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/21/2024
03/28/2024
IVT
4.5g
Q6
CAP MR
Checking Final Appropriateness
03/21/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/21/2024
04/04/2024
IVT
4.5g
Q6
CAP HIGH RISK
Checking Final Appropriateness